Bismuth-Based First-Line Therapy for <i>Helicobacter pylori</i> Eradication in Type 2 Diabetes Mellitus Patients

Abstract

The bismuth-based quadruple eradication regimen as first-line therapy is safe, tolerable and achieves a high cure rate in patients with DM, and successful eradication may be beneficial on dyspeptic symptoms.